Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Posts
- Category: important (continued)
- FDA approves a new drug for symptoms of Huntington's disease
- FDA Approves Second Drug for Huntington Disease Symptom
- First Huntington's patients dosed with 'gene silencing' drug
- First Patient Enrolled in Pivotal Study of RG6042 (IONIS-HTT Rx) for People with Huntington's Disease
- Fresh Updates from First Huntingtin Lowering Study Publication
- Gene variants that modify Huntington’s disease symptom onset could lead to new therapeutic strategies
- Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial
- Genetic modifier for Huntington’s disease progression identified
- GLOBAL HUNTINGTON’S DISEASE PATIENT ADVOCACY ORGANIZATIONS UNITE TO FORM HUNTINGTON’S DISEASE COALITION FOR PATIENT ENGAGEMENT (HD-COPE)
- Harnessing the power of viruses to treat Huntington's disease
- HD InsightsA - H u n t i n g t o n d i s e a s e r e s e a r c h Issue No 12 -- Fall 2015 p e r i o d i c a l
- HD mice provide a useful failure
- How a Silly Putty ingredient could advance stem cell therapies
- How close are we to a cure for Huntington’s?
- How NOT to write a news article about a clinical trial
- Human skin cells reprogrammed directly into brain cells
- Huntingtina, le due facce di una proteina
- Huntington disease
- Huntington drug successfully lowers levels of disease-causing protein
- Huntington proteins and their nasty 'social network'
- Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
- Huntington's disease goes viral as UniQure inches ahead in gene therapy race
- Huntington's Disease Monkeys Display Progressive Clinical Changes and Neurodegeneration
- Huntington's disease protein controls movement of precious cargo inside cells, study finds
- Huntington's Disease Therapeutics Conference 2014: day 1
- Huntington's Disease Therapeutics Conference 2014: day 2
- Huntington's Disease Therapeutics Conference 2016 - day 1
- Huntington's Disease Therapeutics Conference 2016 - day 2
- Huntington's Disease Therapeutics Conference 2016 - day 3
- Huntington’s Disease Protein Helps Wire the Young Brain
- Huntington’s disease-causing DNA repeat mutations reversed in the lab
- Huntington’s research results in treatment advance
- Huntington’s therapy discovered at Stanford shows positive results in humans
- IBM Researchers' New Approach To Huntington's Could Lead To Significant Breakthrough In Therapy
- Il futuro del trattamento della Malattia di Huntington
- Indian Researchers Find Insulin Clue to Huntington’s Disease
- Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease
- Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
- IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease
- Is genetic testing humans playing God?
- Isis Pharmaceuticals Initiates Clinical Study of ISIS-HTT Rx in Patients With Huntington's Disease
- IXICO awarded two further contracts in Huntington's disease
- Jackson Laboratory researchers find new mechanism for neurodegeneration
- Jumping genes: Huntington's disease protein invades brain transplants
- LA DIAGNOSI PREIMPIANTO PER MALATTIE GENETICHE: LA SPERANZA CHE LA CORTE COSTITUZIONALE FACCIA CADERE IL DIVIETO IMPOSTO DALLA LEGGE 40
- La scienza ci salverà
- La tetrabenazina nella terapia dei movimenti coreici: il punto di vista di Jo Jankovic
- Landmark Huntington's trial starts
- Major Wellcome Trust award to UCL boosts Huntington’s disease research
- Malattia di Huntington, la trieptanoina migliora il metabolismo energetico del cervello
Plugin by dagondesign.com
